NEW YORK (GenomeWeb) – Protagen said today that it is collaborating with the German National Center for Tumor Diseases (NCT) Heidelberg to identify biomarkers for predicting response to immunotherapy in melanoma patients.

The work will use Protagen's SeroTag platform, which simultaneously measures autoantibody levels for thousands of antigens to detect expression patterns linked to disease or patient response to particular therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.